Aspiriant LLC’s Arcellx ACLX Stock Holding History

Aspiriant LLC’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,332	Closed	-$842K	–	401
2026 Q1	$842K	Sell	7,332 -578	-7%	-$51K	0.02%	167
2025 Q4	$516K	Buy	+7,910	New	+$631K	0.01%	209

Other funds holding ACLX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aspiriant LLC's ACLX Position: Q2 2026 in Review

Aspiriant LLC sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 7,332 shares — an estimated $842K sold.

Aspiriant LLC first reported a position in ACLX in Q4 2025 and held it in 2 quarters. The position peaked at $842K in Q1 2026. 1 fund tracked by Wall St. Rank holds ACLX as of Q2 2026.

Aspiriant LLC reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
Aspiriant LLC sold 7,332 Arcellx shares in Q2 2026, an estimated $842K.
Aspiriant LLC first reported a position in Arcellx in Q4 2025 and held it in 2 quarters.
Aspiriant LLC's Arcellx position peaked at $842K in Q1 2026.
1 fund tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.